ES509179A0 - "un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen". - Google Patents

"un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen".

Info

Publication number
ES509179A0
ES509179A0 ES509179A ES509179A ES509179A0 ES 509179 A0 ES509179 A0 ES 509179A0 ES 509179 A ES509179 A ES 509179A ES 509179 A ES509179 A ES 509179A ES 509179 A0 ES509179 A0 ES 509179A0
Authority
ES
Spain
Prior art keywords
flurbiprofen
manufacture
pharmaceutical composition
therapeutic agent
delayed delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES509179A
Other languages
English (en)
Other versions
ES8301629A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co PLC filed Critical Boots Co PLC
Publication of ES8301629A1 publication Critical patent/ES8301629A1/es
Publication of ES509179A0 publication Critical patent/ES509179A0/es
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES509179A 1980-01-11 1982-01-29 "un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen". Granted ES509179A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments

Publications (2)

Publication Number Publication Date
ES8301629A1 ES8301629A1 (es) 1982-12-16
ES509179A0 true ES509179A0 (es) 1982-12-16

Family

ID=26808896

Family Applications (2)

Application Number Title Priority Date Filing Date
ES498369A Expired ES8205353A1 (es) 1980-01-11 1981-01-08 Un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en formade pastillas que contienen aci-dos acetilsalicilico.
ES509179A Granted ES509179A0 (es) 1980-01-11 1982-01-29 "un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen".

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES498369A Expired ES8205353A1 (es) 1980-01-11 1981-01-08 Un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en formade pastillas que contienen aci-dos acetilsalicilico.

Country Status (22)

Country Link
JP (1) JPS56103110A (es)
AT (1) AT374681B (es)
AU (1) AU542824B2 (es)
BE (1) BE886998A (es)
CA (1) CA1140466A (es)
CH (1) CH646604A5 (es)
DE (1) DE3100191A1 (es)
DK (1) DK6181A (es)
ES (2) ES8205353A1 (es)
FI (1) FI76927C (es)
FR (1) FR2473308B1 (es)
GB (1) GB2067072B (es)
GR (1) GR73843B (es)
IE (1) IE50806B1 (es)
IN (1) IN151913B (es)
IT (1) IT1221041B (es)
LU (1) LU83052A1 (es)
NL (1) NL8100037A (es)
NO (1) NO156153C (es)
NZ (1) NZ195933A (es)
SE (1) SE447450B (es)
ZA (1) ZA81136B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
ES2054613T3 (es) * 1985-12-27 1994-08-16 Sumitomo Pharma Un metodo para preparar una formulacion de liberacion mantenida.
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
NZ223619A (en) * 1987-02-27 1990-10-26 Lilly Co Eli Sustained release tablet containing cefaclor, a hydrophilic polymer and an acrylic polymer
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
WO1997002019A1 (en) 1995-06-30 1997-01-23 Baylor University Polyester/carboxylic acid composite materials

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL128902C (es) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
IT1221041B (it) 1990-06-21
FI76927C (fi) 1989-01-10
CA1140466A (en) 1983-02-01
AU542824B2 (en) 1985-03-14
AT374681B (de) 1984-05-25
DE3100191C2 (es) 1988-09-01
CH646604A5 (fr) 1984-12-14
LU83052A1 (fr) 1982-09-10
AU6597681A (en) 1981-07-16
ZA81136B (en) 1982-01-27
GR73843B (es) 1984-05-07
ES8301629A1 (es) 1982-12-16
NZ195933A (en) 1982-11-23
BE886998A (fr) 1981-07-08
FR2473308A1 (fr) 1981-07-17
NO156153B (no) 1987-04-27
NL8100037A (nl) 1981-08-03
IN151913B (es) 1983-09-03
DK6181A (da) 1981-07-12
FI810056L (fi) 1981-07-12
JPS56103110A (en) 1981-08-18
SE8100104L (sv) 1981-07-12
FI76927B (fi) 1988-09-30
DE3100191A1 (de) 1981-12-10
ES498369A0 (es) 1982-06-01
IT8147537A0 (it) 1981-01-09
GB2067072B (en) 1983-08-10
GB2067072A (en) 1981-07-22
NO156153C (no) 1987-08-05
IE50806B1 (en) 1986-07-23
NO810062L (no) 1981-07-13
IE810036L (en) 1981-07-11
FR2473308B1 (fr) 1985-07-19
ATA5481A (de) 1983-10-15
ES8205353A1 (es) 1982-06-01
SE447450B (sv) 1986-11-17

Similar Documents

Publication Publication Date Title
ES509179A0 (es) "un metodo de fabricacion de una composicion farmaceutica de liberacion retardada en forma de pastillas que contiene como agente terapeutico ibuprofen o flurbiprofen".
IT8449184A1 (it) Agente attivo nel trattamento di tossicomania in particolare da eroina costituito da una composizione contenente ibogaina
IT1190929B (it) Diidropiridine dotate di azione inotropa positiva,composti,loro impiego in prodotti medicinali e procedimento per la loro preparazione
JPS57112359A (en) Carboxylalkyl dipeptide, manufacture and medicinal composition
JPS5718671A (en) Aminocyclopentane alkenoic acid and esters thereof,manufacture and drug composition
PT88404A (pt) Dosage form comprising fast agent delivery followed by slow agent delivery
DE3485408D1 (de) Pharmazeutische zusammensetzung.
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
AU521053B2 (en) Medicament dosage form
JPS5798281A (en) Azabicyclooctane-carboxylic acid, manufacture and pharmaceutical composition containing same
IT8120578A0 (it) Composizione farmaceutica a rilascio controllato contenente ibuprofen.
ZA818559B (en) Pharmaceutical composition in the form of a gel containing acetylsalicylic acid
JPS56140992A (en) Unsaturated benzamides, manufacture and medicinal composition containing them
IT8125902A0 (it) Composizione copolimerica e impianto di erogazione per fornire una pellicola di barriera protettiva per la pelle.
JPS57120506A (en) Liquid dental composition, manufacture and manufacturing package
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
EP0084053A4 (en) Medicines and the use of Sn or Cr protoporphyrin for its manufacture.
IT7968195A0 (it) Procedimento per la fabbricazione di un dispensatore di agente attivo ad azione osmotica particolarmente in forma di pastiglia medicamentosa
ATE36455T1 (de) Pharmazeutische zusammensetzungen.
ATE8460T1 (de) Pharmazeutische praeparate und deren herstellung.
IT1142164B (it) Composizione farmaceutica per l'impiego in un aumento di pressione endocranica
JPS56154472A (en) Thiazole compound, its manufacture and medicinal composition containing it
DE68902056T2 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
MX9202984A (es) Composiciones farmaceuticas que contienen salbutamol.
FR2509611B1 (fr) Nouvel agent anti-acide et composition pharmaceutique le contenant